policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Therapeutic pet food health claims
The FDA uses enforcement discretion in overseeing certain pet food claims. While many of these could legally be considered drugs, certain claims are…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
JAVMA news
FDA urges collaboration as dilated cardiomyopathy afflicts more dogs
About 1,100 dogs have developed dilated cardiomyopathy in the past seven years. Retrospective data show potential links with diet, and FDA officials…
JAVMA news
Nutritional conversations, front and center
Veterinarians can navigate nutrition and diet conversations by leveraging some simple tools such as sending out a nutritional assessment before…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.